Literature DB >> 14709355

A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease.

Katsunori Ikewaki1, Akira Matsunaga, Hua Han, Hisayuki Watanabe, Akira Endo, Jun-ichiro Tohyama, Mamoru Kuno, Jun-ichi Mogi, Ken-ichi Sugimoto, Norio Tada, Jun Sasaki, Seibu Mochizuki.   

Abstract

Familial HDL deficiency (FHD) is a rare autosomal dominant lipoprotein disorder. We describe a novel genetic variant of the apolipoprotein A-I (apoA-I) gene resulting in FHD. The proband is a 51-year-old woman who was hospitalized due to severe heart failure. Her plasma HDL-cholesterol (C) and apoA-I concentrations were 0.08mmol/l and 1mg/dl, respectively. She exhibited corneal opacities and planar xanthomas on eyelids and elbows. Coronary angiography demonstrated extensive obstructions in two major vessels. Genomic DNA sequencing of the patient's apoA-I gene revealed a homozygosity for a GC deletion between 5 GC repeats in exon 4, creating a frameshift and a stop codon at residue 178. We designated this mutation as apoA-I Shinbashi. The proband's father, son, and daughter were found to be heterozygous for this mutation and their HDL-C and apoA-I levels were about half of normal levels, demonstrating a gene dosage effect. The father underwent coronary bypass surgery at age of 70 years. Lecithin-cholesterol acyltransferase (LCAT) activity was decreased by 63% in the homozygote and 31% in heterozygotes, respectively. This new case of apoA-I deficiency, apoA-I Shinbashi, is the first case involving a single gene defect of the apoA-I gene to develop all the characteristics for apoA-I deficiency, including premature coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14709355     DOI: 10.1016/j.atherosclerosis.2003.09.024

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

Review 1.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

2.  Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice.

Authors:  Jing Liu; Hong Lu; Deborah A Howatt; Anju Balakrishnan; Jessica J Moorleghen; Mary Sorci-Thomas; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-04       Impact factor: 8.311

Review 3.  Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.

Authors:  Vassilis I Zannis; Angeliki Chroni; Monty Krieger
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

4.  Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein-deficiency states.

Authors:  Raul D Santos; Bela F Asztalos; Lilton R C Martinez; Marcio H Miname; Eliana Polisecki; Ernst J Schaefer
Journal:  J Clin Lipidol       Date:  2008-06-13       Impact factor: 4.766

5.  Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach.

Authors:  Maira Ladeia R Curti; Patrícia Jacob; Maria Carolina Borges; Marcelo Macedo Rogero; Sandra Roberta G Ferreira
Journal:  J Obes       Date:  2011-05-23

6.  Corneal vesicles accumulate collagen VI associated with tissue remodeling in apolipoprotein a-I deficiency: a case report.

Authors:  Hiroyuki Namba; Mari Narumi; Shinji Susa; Rintaro Ohe; Takeo Kato; Mitsunori Yamakawa; Hidetoshi Yamashita
Journal:  BMC Ophthalmol       Date:  2017-02-08       Impact factor: 2.209

7.  Expression of human hepatic lipase negatively impacts apolipoprotein A-I production in primary hepatocytes from Lipc-null mice.

Authors:  Michelle Bamji-Mirza; Wandong Zhang; Zemin Yao
Journal:  J Biomed Res       Date:  2014-03-20

8.  Novel 6-bp deletion in MEF2A linked to premature coronary artery disease in a large Chinese family.

Authors:  Dong-Ling Xu; Hong-Liang Tian; Wei-Li Cai; Jie Zheng; Min Gao; Ming-Xiang Zhang; Zhao-Tong Zheng; Qing-Hua Lu
Journal:  Mol Med Rep       Date:  2016-05-18       Impact factor: 2.952

Review 9.  Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism.

Authors:  Marcos Palacio Rojas; Carem Prieto; Valmore Bermúdez; Carlos Garicano; Trina Núñez Nava; María Sofía Martínez; Juan Salazar; Edward Rojas; Arturo Pérez; Paulo Marca Vicuña; Natalia González Martínez; Santiago Maldonado Parra; Kyle Hoedebecke; Rosanna D'Addosio; Clímaco Cano; Joselyn Rojas
Journal:  F1000Res       Date:  2017-11-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.